Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Svetlana Yurevna Smirnova"'
Autor:
L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian, G.M. Galstyan
Publikováno v:
Clinical oncohematology. 15:349-355
Background. The standard and effective treatment of hairy cell leukemia (HCL) involves purine analogs, interferon-а (IFN-а) administration, and splenectomy. However, primary resistant HCL and early relapses (within 2-3 years after achieving remissi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab6b181a4a46de4a8ee257ee3b62ff12
https://doi.org/10.21320/2500-2139-2022-15-4-349-355
https://doi.org/10.21320/2500-2139-2022-15-4-349-355
Autor:
I.A. Shupletsova, A.B. Fedorov, G.A. Yatsyk, Al'-Radi Ls, S.A. Makhinya, Alla M. Kovrigina, Moiseeva Tn, Svetlana Yurevna Smirnova, N.V. Volkov
Publikováno v:
Clinical oncohematology. 14:188-192
Hodgkin’s lymphoma is a tumor characterized by predominant lesions in lymph nodes. Primary extranodal lesions are exceedingly rare. In the now available world literature, there are only single observations of classical Hodgkin’s lymphoma with ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83ae7a981f992129107e8b0306514810
https://doi.org/10.21320/2500-2139-2021-14-2-188-192
https://doi.org/10.21320/2500-2139-2021-14-2-188-192